Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Abilify (aripiprazole) Tablets, Otsuka America Pharmaceutical, NDA 21-436/S1 Abilify (aripiprazole) Tablets, 2, 5, 10, 15, 20 and 30 mg, Otsuka Pharmaceutical Co., Ltd. NDA 21-436 Abilify (aripiprazole) Tablets, Otsuka | Abilify (aripiprazole) Tablets, Otsuka Maryland Research, New or Modified Indication | Abilify (aripiprazole) Oral Solution, Otsuka America Pharma, Approval | Abilify (aripiprazole) Tablets, Otsuka Maryland Research, New or Modified Indication & Labeling Revision | Abilify Oral Solution, Otsuka Maryland Research, Labeling Revision | Abilify (aripiprazole) Tablets, Bristol-Myers Squibb, Labeling Revision | Abilify (aripiprazole) Oral Solution, Bristol-Myers Squibb, Labeling Revision | Discmelt (aripiprazole) orally disintegrating tablets, Otsuka Pharma, Approval | Abilify (aripiprazole) Tablets, Otsuka Pharma, Labeling Revision | Abilify (aripiprazole) Oral Solution, Otsuka Pharma, Labeling Revision | Abilify (aripiprazole) injection, Otsuka, Approval | Abilify (aripiprazole) Tablets, Otsuka, Labeling Revision | Abilify (aripiprazole) Oral Solution, Otsuka, Labeling Revision | Abilify Discmelt (aripiprazole) Orally Disintegrating Tablets, Otsuka, Labeling Revision | Abilify (aripiprazole) Intramuscular Injection, Otsuka, Labeling Revision | Abilify (aripiprazole) DISCMELT, Otsuka, Labeling Revision | Abilify (aripiprazole) Oral Solution, Otsuka, Labeling Revision | Abilify (aripiprazole) Tablets, Otsuka, Labeling Revision | ABILIFY (aripiprazole) Tablets, Otsuka Pharma, Patient Population Altered | ABILIFY DISCMELT (aripiprazole) Orally Disintegrating Tablets, Otsuka Pharma, Patient Population Altered | ABILIFY (aripiprazole) Oral Solution, Otsuka Pharma, Patient Population Altered | ABILIFY (aripiprazole) Injection Intramuscular, Otsuka Pharma, Patient Population Altered | ABILIFY (aripiprazole) Tablets, Otsuka Pharma, New or Modified Indication | ABILIFY (aripiprazole) Oral Solution, Otsuka Pharma, New or Modified Indication | ABILIFY (aripiprazole) Orally Disintegrating Tablets, Otsuka Pharma, New or Modified Indication | ABILIFY (aripiprazole) Injection Intramuscular, Otsuka Pharma, New or Modified Indication | Abilify (aripiprazole) Tablets, Otsuka Pharma, Patient Population Altered | Abilify (aripiprazole) Tablets, Otsuka, Labeling Revision | Abilify Discmelt (aripiprazole) Orally Disintegrating Tablets, Otsuka, Labeling Revision | Abilify (aripiprazole) Oral Solution, Otsuka, Labeling Revision | Abilify (aripiprazole) Injection, Otsuka, Labeling Revision | Abilify (aripiprazole) Orally Disintegrating Tablet, Otsuka Pharmaceutical Co., Ltd., New Dosage Regimen | Abilify (aripiprazole) Orally Disintegrating Tablet, Otsuka Pharmaceutical Co., Ltd., New or Modified Indication | Abilify (aripiprazole) Intramuscular Injection, Otsuka Pharmaceutical Co., Ltd., New Dosage Regimen | Abilify (aripiprazole) Intramuscular Injection, Otsuka Pharmaceutical Co., Ltd., New or Modified Indication | Abilify (aripiprazole) Tablet, Otsuka Pharmaceutical Co., Ltd., New Dosage Regimen | Abilify (aripiprazole) Tablet, Otsuka Pharmaceutical Co., Ltd., New or Modified Indication | Abilify (aripiprazole) Oral Solution, Otsuka Pharmaceutical Co., Ltd., New Dosage Regimen | Abilify (aripiprazole) Oral Solution, Otsuka Pharmaceutical Co., Ltd., New or Modified Indication | Abilify (aripiprazole) Intramuscular Injection, Otsuka Pharmaceutical Development and Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Oral Solution, Otsuka Pharmaceutical Development and Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Orally Disintegrating Tablets, Otsuka Pharmaceutical Development and Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Tablets, Otsuka Pharmaceutical Development and Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Tablets, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Oral Solution, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Orally Disintegrating Tablets, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Injection, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | ABILIFY (aripiprazole) Tablets, Otsuka Pharmaceutical Company, Ltd., Efficacy Supp. w/Clinical Data | Abilify (aripiprazole) Injection, Otsuka Pharmaceutical Company, Ltd., Labeling Revision | Abilify (aripiprazole) Intramuscular Injection, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Orally Disintegrating Tablet, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Oral Solution, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Tablets, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Intramuscular Injection, Otsuka Pharmaceutical, Efficacy Supplement with Clinical Data to Support | Abilify (aripiprazole) Oral Solution, Otsuka Pharmaceutical, Efficacy Supplement with Clinical Data to Support | Abilify (aripiprazole) Orally Disintegrating Tablets, Otsuka Pharmaceutical, Efficacy Supplement with Clinical Data to Support | Abilify (aripiprazole) Tablets, Otsuka Pharmaceutical, Efficacy Supplement with Clinical Data to Support | Abilify (aripiprazole) Injection, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Oral Solution, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Orally-Disintegrating Tablet, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision | Abilify (aripiprazole) Tablets, Otsuka Pharmaceutical Development & Commercialization, Inc., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com